Related by context. All words. (Click for frequent words.) 79 regulatory approvals 75 requisite regulatory approvals 70 regulatory approval 70 requisite approvals 69 shareholder approvals 67 regulatory clearances 67 governmental approvals 67 applicable regulatory approvals 64 stockholder approvals 63 customary regulatory approvals 58 approvals 58 customary closing conditions 58 stockholder approval 57 antitrust clearance 57 definitive documentation 56 customary closing 55 lender consents 54 requisite stockholder 54 consents authorizations 54 regulatory authorizations 53 obtaining regulatory approvals 53 satisfactory due diligence 53 Pending regulatory approvals 53 requisite consents 52 definitive agreements 52 Consummation 52 disinterested shareholder 51 Proposed Transaction 50 Regulatory Approvals 50 Proposed Transactions 49 HSR clearance 49 FIRB approval 49 successfully integrate 49 without limitation Terremark 49 securityholder approvals 48 disinterested Shareholder approval 48 unitholder approval 48 market PolyHeme commercially 48 Proposed Financing 48 Requisite Consents 48 PDTI 48 viii inability 47 Shareholder Approval 47 Proposed Qualifying Transaction 47 securityholder approval 47 Regulatory Approval 47 Business Combination 47 regarding Heska 47 Allovectin 7 r 47 valid acceptances 47 otherfactors 46 Mago ® 46 attaching thereto 46 Lebowa transaction 46 CORLUX CORT # 46 without limitation 46 Hanlong transaction 46 transactions contemplated 46 Second Tranche 46 approval 46 successfully commercialize Iluvien 46 BiDil XR drug 46 Prokhorov Onexim 45 commercialize telaprevir 45 WDEQ Permit 45 confirmatory due diligence 45 consummation 45 warrantholders 45 GLASSIA ™ 45 Aeroflex stockholders 45 SFDA approval 45 ReNvision 45 Biomerge 45 Definitive Agreement 45 shares issuable pursuant 45 Tendering holders 45 Arrangement Agreement 45 risks anduncertainties 45 risksand uncertainties 45 Yahoo capitulates 45 Announce Shareholder Approval 45 chemosaturation system 45 DSL.net s 45 AnorMED expectation 45 mutually acceptable definitive 45 Brokered Financing 45 statutory clearances 44 NitroMed BiDil 44 Aurvista 44 Concurrent Financing 44 affecting BEO Bancorp 44 thetransaction 44 Acquisition Transaction 44 STRIANT ® 44 ability tosuccessfully 44 consummating acquisitions 44 permits consents 44 Upon consummation 44 LOI contemplates 44 Gestiva TM 44 FIPB approval 44 Rotarix R 44 First Tranche 44 GHL Acquisition stockholders 44 conditioned upon 44 private placement 44 promote ceftobiprole 44 legal proceedings xxi 44 PLIVA dd 43 limitedto 43 PolyHeme successfully 43 PRRF 43 crolibulin TM 43 Solfotara Mining Corporation 43 TNRO 43 Graniz Loan 43 Definitive Agreements 43 consents 43 OTCBB CPEU 43 Canetic Unitholders 43 Recapitalization Transaction 43 Yima project 43 TechTeam Global stockholders 43 Metabasis stockholders 43 execute supplemental indenture 43 Proposed Acquisition 43 optionholders 43 Allovectin 7 R 43 mutually satisfactory definitive 43 definitive agreement 43 including withoutlimitation 43 Reverse Takeover 43 validly tendered Notes 43 Cellu Tissue stockholders 43 Combination Transaction 43 Whitewash Waiver 43 Subscription Receipts 43 Merger Agreement 43 Kensington Leasing 43 render PolyHeme obsolete 43 c SIGA 43 Company Skouries Olympias 43 DRAXIS 43 Tostrex 43 VBV 43 PentaStaph 43 MethyPatch 43 Eligard R 43 Financing Condition 43 causeactual results 43 Debenture Financing 43 risks associatedwith 43 requisite Consents 43 Risks uncertainties 43 Prelude SkinPrep Systems 43 Qinnan PSC 43 PharMerica LTC Transaction 43 MOU contemplates 43 Orphan Drug designation 42 SynthRx 42 redomestication 42 Vitaros R 42 regardingthe 42 issuable pursuant 42 CompAir acquisition 42 ADSI reliance 42 ComfortScan system 42 tendered pursuant 42 TP# CETi 1 42 Orosi Mill project 42 ArPetrol Transaction 42 Private Placement 42 Richard Muruve 42 Hart Scott Rodino 42 USFDA approval 42 Sangaredi Refinery Project 42 Cell Genesys stockholders 42 CapGen Offering 42 Proposed Combination 42 Non Brokered Offering 42 AMEX TMY 42 Merger Transactions 42 bankable feasibility study 42 Positive Feasibility Study 42 Acetavance TM 42 validly revoked 42 incorporate CXA 42 Junovan 42 Algatec 42 AMEX IVX LSE IVX.L 42 Qualifying Transaction 42 Antitrust Improvements Act 42 differmaterially 42 Share Purchase Agreement 42 ANDA submission 42 OTCBB BTEM 42 Chihong 42 Neurogen stockholders 42 MAb therapy 42 involve risks anduncertainties 42 d SIGA 42 Nemak transaction 42 Shigamabs 42 consummated 42 theacquisition 42 Reincorporation 42 Fronteer Offer 42 Sleeping Giant mines 42 Somaxon ability 42 FACTIVE tablets 42 Proposed Amalgamation 42 Acquisition Agreement 42 ZALBIN 42 asset monetizations 42 Brokered Offering 42 developments affecting SIAF 42 securities issuable pursuant 41 Compulsory Acquisition 41 Vitaros 41 marketed GeoVax raises 41 MONOVISC 41 convertible debenture financing 41 Closes Flow Through 41 Bioenvision dependence 41 authorizations 41 eprodisate KIACTA TM 41 Shire Attention Deficit 41 Asentar TM 41 OPAXIO pixantrone 41 transfusional iron overload 41 Fampridine SR Acorda Therapeutics 41 Fund TSX CHW.UN 41 Increlex TM 41 EGRIFTA ™ 41 Kinsevere copper mine 41 ELEVESS 41 UrAsia Energy 41 Sabine Pass LNG 41 notlimited 41 supplemental indenture 41 shall rank pari 41 IMA Barytex 41 crinobulin 41 regulatory 41 differ materially fromthose 41 Xenith Corporation 41 Glen Dhu LP 41 Cease Trade Orders 41 DGFC 41 Completes Previously Announced 41 Nu Mex 41 Rozetta Cell 41 alogliptin NDA 41 compound CIP FENOFIBRATE 41 statements arebased 41 successfully commercialize Silenor 41 Combination Agreement 41 Xechem Nigeria 41 Arrangement 41 broker warrants exercisable 41 Serica Energy plc 41 VYVANSE TM lisdexamfetamine 41 BOWMORE 41 AENY common 41 successfully commercialized 41 statementsregarding 41 YSV 41 OneEx 41 Solasia 41 customary representations warranties 41 expectations anticipations estimates 41 Wikifamilies 41 Paredones Amarillos Project 41 Lumera stockholders 41 Subscription Receipt 41 vernakalant iv 41 Securities andExchange Commission 41 Amalgamation 41 QT Financing 41 candidate Ramoplanin 41 accretive 41 MedMira rapid 41 Tender Offer Memorandum 41 Chaim Lebovits President 41 irrevocable undertakings 41 BEMA Granisetron 41 GLP toxicology studies 41 Rhein Biotech NV 41 anduncertainties 41 CalciTech products 41 QMLP 41 Orphan Drug designations 41 bookrunning managers 41 Proposed Takeover 41 proceeds therefrom 41 Rights Offering 41 ATS Andlauer 41 Eurogas International 41 CanElson 41 Completion 41 Recapitalization Agreement 41 definitive proxy 41 Fast Track designations 41 Amends Terms 41 SEC Form #F 41 Medigen 41 Receives Shareholder Approval 41 Kaneb Partners 41 Z5 Technologies 41 CUSF 41 No Objection Letter 41 Pharmachem Revised Offer 41 VANTAS 41 nonoccurrence 41 affecting ChinaNet 41 validly deposited 41 RPTN common 41 Cellegy 41 Medtronic Annual Report 40 risks uncertainties 40 GPNL 40 non waivable 40 resale restriction 40 Aumento 40 Handysize vessels 40 Varvarinskoye Project 40 shares issuable upon 40 Rectogesic 40 requirements xxii 40 Merger Transaction 40 SonoPrep device 40 MICEX RTS 40 synergies therefrom 40 MagPotash 40 ultra deepwater drillships 40 uncertaintiesthat 40 prospectus supplement relating 40 Nio Metals 40 materially adversely affect 40 Final Approval 40 manufacture PolyHeme 40 purchase warrants exercisable 40 DASA Finance 40 Consummates 40 Medicis Inamed 40 Fancamp Announces 40 EIFH 40 Orphan Drug Status 40 Gwenco 40 Completes Second Tranche 40 faropenem 40 Subscription Receipt Offering 40 Solfotara 40 AnGes 40 BlueCreek 40 couldcause actual results 40 OSISKO 40 USEB Chapter 40 EHSK 40 Icoworks Holdings 40 Berezitovy Gold Mine 40 uncertainties 40 vesting provisions 40 sirtuin modulators 40 repopulate CNS 40 Offer Documents 40 Investigational Device Exemption 40 Aphthasol R 40 unanticipated geological 40 OFCD Optionally Fully 40 Frontino Acquisition 40 novel MetAP 2 40 Gentamicin Surgical Implant 40 Escrow Release Conditions 40 withrespect 40 cytokine immunomodulator 40 affect Petroflow 40 practicable thereafter 40 proration procedures 40 deems immaterial 40 adversely affect Linktone 40 Closes Non Brokered 40 acquisitions divestitures mergers 40 MPEH ™ 40 Invicorp R 40 BiDil XR 40 Contingent Value Right 40 Fulun Steel 40 proprietary Capillary Aerosolization Technology 40 Ceragenin ™ technology 40 redomiciliation 40 businesses trademarks tradenames 40 Antitrust Improvement 40 Angiotech Entities 40 Exelbine 40 Enlarged Group 40 EGRIFTA TM 40 Offer Period 40 Cheniere Partners 40 Plenaxis R 40 & Workover Fluids 40 Substantial Issuer Bid 40 Company TSXV ARQ 40 histamine dihydrochloride 40 Consent Fees 40 Complete Response letter 40 Oremex Gold 40 Auxilium anticipates 40 Issuer Bid 40 Refinancing Transactions 40 Waratah Coal filings 40 Edgen Corporation 40 FDA Approvable Letter 40 arenot limited 40 Company TSX QEC 40 preliminary prospectus 40 Bluehill ID 40 Stock Purchase Agreement 40 Mitsue Pipelines 40 Equitex 40 TRUSTCASH 40 Approvable Letter 40 NRGP unitholders 40 rStar 40 gross proceeds 40 Biologics License Application 40 supplemental indentures 40 Flow Through Private Placement 40 drug ISA# 40 Bullabulling Gold Project 40 Phase IIa clinical trials 40 Minsud 40 Washmax 40 difficulties foreseeing 40 Modrenal R 40 Spin Off Transaction 40 Securities Purchase Agreement 40 Qualifying Transaction pursuant 40 vernakalant oral 40 title taxation sociopolitical 40 oversubscription privilege 40 Karchiga Project 40 indenture amendments 40 Crux liquids project 40 TSX VENTURE RM OTCQX 40 telaprevir VX 40 Soliris TM eculizumab 40 Equigold shareholders 40 Transaction 40 Bellekeno Mine 40 Common Share Offering 40 Metallic Ventures 40 BLA submission 40 Prochieve R 40 Dvoinoye 40 OTCBB PHUN 40 OrCrude TM process 40 Keystone Pipeline System 40 DeeThree 40 EvaMist NDA submission 40 tivozanib AV 40 ADSs 40 XL# anticancer compounds 39 unanticipated difficulties 39 amendments thereto 39 vii Cubist ability 39 Subscription Agreement 39 Receives Conditional 39 Stockholder Approval 39 Calixa 39 AOLS Holdings 39 Fast Track designation 39 Novavax filings 39 Mediaseed R 39 Safe Harbors created 39 JHP Pharmaceuticals LLC 39 uncertainties inherent 39 reorganized WMI 39 TSX PWE FRANKFURT 39 delisting proceedings 39 CEFF financings subject 39 Falconbridge Acquisition 39 Loramyc 39 representations warranties covenants 39 ZCI Offer 39 rank pari passu 39 aresubject 39 Hoku Materials 39 SILENOR TM 39 multipurpose tweendeckers 39 differ materially 39 JSAT MOBILE 39 Cellegesic 39 Quartz Mining 39 AzaSite Plus 39 TRISENOX ® 39 ourability 39 deploy MDCE services 39 Redomestication 39 Nabi HB Intravenous 39 commercialize NicVAX 39 Somatuline R Autogel R 39 Shun Cheng HK 39 Synatom 39 Conditional Approval 39 Announces Shareholder Approval 39 Kobex 39 Kevitsa project 39 FT Units subscribed 39 Material License 39 issuable upon exercise 39 TSX VENTURE PPY.A TSX 39 InSite reliance 39 financings 39 naronapride 39 capture exosomes 39 prospectus relating 39 Neurobionix 39 Terrenex 39 Completes Non Brokered 39 sublicense agreements 39 VBV LLC 39 Serica Energy plc Serica 39 Connected Persons 39 Make Normal Course 39 Sular formulation 39 Mineralfields Group 39 Amex VGZ 39 CholeraGarde R Peru 39 Consents 39 SansRosa 39 Mylan ANDA 39 Mexgold 39 HEPLISAV 39 5 lipoxygenase inhibitor 39 Bonus Warrants 39 requisite clearances 39 Closing Date 39 Signs Definitive 39 SILENOR ™ 39 dimesylate Attention Deficit 39 Generx TM 39 BioZone 39 B Preferred Stock 39 ADSs tendered 39 CoStar stent 39 Override Agreement 39 Proposed Merger 39 farmouts 39 Entereg TM 39 xxi 39 Non Brokered Placement 39 Limited TSX TCK.B 39 farmout 39 ranking pari passu 39 Flow Through Financing 39 Orphan Drug status 39 Comdial Corporation 39 TSX VENTURE FWR announces 39 Inhibiton 39 Inducement Warrants 39 warrantholder approval 39 Specifications pricing 39 Crowflight Announces 39 Peregrino field 39 Acapodene R 39 liquidating distributions 39 Bioenvision filings 39 Multiplied Media announces 39 Subordinated LP 39 Rocmec Closes 39 Bellekeno mine 39 Completes Asset 39 forward lookingstatements 39 regasification terminals 39 Lero Gold 39 testosterone buccal system 39 affecting Amarin 39 Bogoso sulfide expansion 39 TSX DEJ announces 39 Galore Creek Partnership 39 Symphony tCGM 39 differ materiallyfrom 39 BugOil R 39 Zanaflex Capsules competition 39 vii 39 Kind Tender Offer 39 Amalgamation Agreement 39 rapid prototyping patents 39 Vistior 39 peramivir BCX 39 OAO TGC 39 Sandstorm Resources 39 Aloprim TM allopurinol sodium 39 pursuant thereto 39 Kunekt 39 Kulu copper 39 R rilonacept Injection 39 Loramyc TM 39 Paredones Amarillos gold 39 ZTEST Announces 39 Shire plc Attention Deficit 39 FSRU conversions 39 Alvheim Vilje development 39 ACLARA 39 Suntera 39 Japanese Encephalitis Vaccine 39 thereunder 39 adversely affect FNB 39 DIP Loan 39 risks associated 39 Arehada China 39 Proposed Arrangement 39 GVAX Immunotherapies 39 Goldking 39 European Marketing Authorizations 39 commercialized DURECT 39 Entereg R 39 finder fee payable 39 Final Prospectus 39 Signs Binding Agreement 39 refractory chronic lymphocytic 39 Visian Toric ICL 39 Bucko Lake Mine 39 ARIF II 39 Aurtois 39 NCL PMD 39 orBec R 39 STRIANT R 39 Terminates Agreement 39 brokered Private Placement 39 JVCo 39 NYSE Amex SOQ 39 Securities Purchase Agreements 39 Vertex retains 39 Exploram 39 markets HP Acthar 39 USPoly 39 cause actualresults 39 Urokinase 39 Cytopia shareholders 39 Rights Offering Circular 39 plc VGM 39 subscription receipts 39 AnorMED 39 Dynepo 39 SyntheMed 38 PGP Acquisition 38 Underwriters Exercise 38 JunJing III 38 Stans Energy 38 iVoice shareholders 38 Company TSX CQE 38 Elgaugol 38 transgenically produced product 38 Arigene 38 TSX VENTURE NML 38 cornered amalgamation 38 successfully commercialize 38 Finno Ugric minorities 38 CPL Biologicals 38 Temporary Occupation Permit 38 proprietary punctal plug 38 ORBIT II 38 Power3 patent 38 Shanjin Mining Corporation 38 underwriters overallotment option 38 EPE unitholders 38 Company nanocrystalline materials 38 looking statements includingbut 38 Federated Kaufmann Funds 38 Picchio Pharma 38 Proposed Offer 38 DYNACIN R Tablets 38 FXRE 38 PerClot 38 Fast Track Status 38 Completion Date 38 Amalco Shares 38 Ondansetron Injection 38 co venturers 38 NASDAQ CHIP VeriChip 38 CONBRIZA 38 transactions contemplated thereunder 38 Acceptance Forms 38 Commitment Letter 38 Purifine ® PLC 38 materially impair 38 outstanding indebtedness 38 thecompletion 38 QAB# indacaterol 38 Jinan Fertilizer 38 GSR Bid 38 Valera Pharmaceuticals Inc. 38 Files Shelf Registration Statement 38 BioGold Fuels 38 mifamurtide 38 XL# XL# XL# XL# 38 Shareholders Approve Proposed 38 NovaDel 38 Escrow Issuer 38 HepaGam B R 38 RAPTIVA R 38 Scheme Effective Date 38 Kakanda Project 38 exemptive relief 38 Azixa TM 38 Ceplene TM 38 OGE Enogex Partners LP 38 Prominex 38 Miraculins Announces 38 NeoVisc 38 compound CXA 38 THELIN 38 Global Television MovieTime 38 Announces Non Brokered 38 Mining Licence 38 risksassociated 38 suspensive conditions 38 withoutlimitation 38 Evoltra TM 38 Kyowa Kirin 38 issuable upon 38 commercialize alitretinoin 38 Vitaros ® 38 Shareholders Approve Arrangement 38 DC Bead 38 FACTIVE R gemifloxacin 38 becompleted 38 valtorcitabine 38 Pamrapo Bancorp 38 VRDP 38 Terminates Merger Agreement 38 assume operatorship 38 Sleeping Giant Mine 38 Brookfield Infrastructure 38 CNPCI 38 GasFrac 38 Accelerated Feasibility Study 38 TSX PLB leading 38 Incentive Warrants 38 self affirmed GRAS 38 Flexpipe 38 Mubarek Field 38 dilutive 38 News# editors 38 Receives Stockholder Approval 38 CCU Notes 38 related thereto 38 Announce Early Termination 38 Underwriting Agreement 38 Kirrin Resources Announces 38 Approval 38 applicable Offering Memorandum 38 BioGlue ® 38 GSCT 38 ticker symbol IMM 38 divestitures 38 pharmacokinetic feasibility 38 work stoppages quarantines 38 Metallum 38 Marketing Authorisation Application 38 Acceptance Date 38 strategic participations 38 ASX WPG 38 Syntroleum Process 38 Increases Bought Deal 38 PetroFalcon 38 oral calcitonin 38 Subordinate Voting Shares 38 Bought Deal Offering 38 Conditional Placement 38 Somanta 38 Equity Financing 38 CRINONE ® 8 38 Genaera filings 38 commonstock 38 Shareholders Overwhelmingly Approve 38 Clearant Process ® 38 Kaskattama 38 unsecured indebtedness 38 FMEC 38 NYSE AMEX PLX 38 Segebel 38 Hejia Software 38 Dynegy stockholders 38 HSR Antitrust Improvements 38 Announce Receipt 38 Amends Private Placement 38 Essakane Project 38 authority NMa 38 BioThrax ® 38 DJO Merger 38 Amended Offer 38 ITEMS GENERALLY 38 TSX OBP 38 ASX CFE 38 hyperpigmentation irregular 38 TSX MAE 38 refusal ROFR 38 hoFH 38 reincorporation merger 38 renamed Vodafone Essar 38 Marketing Authorization Applications 38 Closes Merger 38 Definitive Feasibility Study 38 Zila stockholders 38 Kibali Jersey 38 underwriting discounts commissions 38 HSR Waiting Period 38 collaborations Pharmacopeia 38 tantalum lithium tin 38 Final Offer Documents 38 Proprius Pharmaceuticals 38 Vivo TIM 38 Proposed Amendments 38 TRIOLEX HE# APOPTONE HE# 38 gastrointestinal disorders ATI 38 LOPROX R 38 supplemental indenture containing 38 TriPath Oncology 38 shares issuable thereunder 38 Debentures 38 GHIL 38 CBMDF FRANKFURT IY2 announces 38 onto cyanide heap 38 Cash Consideration 38 synergies 38 Brokered Placement 38 CLIA certification 38 Privateco 38 Offeror intends 38 Yangzhou Yalian 38 FastFunds Financial Corporation 38 Argatroban 38 viii 38 Diavik Mine 38 ZEGERID Powder 38 BioSante licensees 38 Form #c# 38 TSX VENTURE EMX 38 symbol GEX 38 Qualifying Transaction QT 38 PLAVIX R patent 38 Hexion Proposal 38 Pashminadepot.com 38 CPIF 38 Bilive TM 38 acquisitions divestitures strategic alliances 38 Inc. Nasdaq SLXA 38 orally bioavailable compound 38 Closes Second Tranche 38 Synerx 38 Poly ICR 38 Tranzeo logo 38 BEO Bancorp. There 38 Orthovita filings 38 market fluctuations investee 38 Tontine Capital 38 Closes Oversubscribed 38 Mergence Corporation 38 Kosan motilin agonist 38 Guinea Alumina Refinery 38 TSX VENTURE ADI 38 NASDAQ PHRM 38 TASE CAMT 38 bilastine 38 Fluviral 38 NSE SUNPHARMA 38 Existing Floating Rate 38 Receives Regulatory 38 Flow Through Offering 38 CNMIM 38 ruxolitinib 38 OTCBB FROI 38 ACAPODENE R 38 Allscripts Eclipsys 38 results ofoperations 38 Oncosphere 38 Inovio pipeline 38 Diavik Diamond Mine 38 Voto III 38 Monovisc 38 Graphic Packaging Corporation 38 Nicotine Conjugate Vaccine 38 Hopper costarred 38 Pre QT Financing 38 TSX EQN ASX EQN 38 Discovery Informatics 38 Marketing Authorization 38 II FTLP 38 AcquisitionCo 38 Kinross Gold Freeport McMoRan 38 Alnylam dependence 38 forodesine HCl 38 Contingent Value Rights 38 forodesine hydrochloride BCX 38 Staff Determination Letter 38 PROCHIEVE 38 IMHL 38 Proposed Randgold Transaction 38 MedCom USA Inc. 38 Pharmos pipeline 38 Stockholders Approve Merger 38 ANS Parties 38 Marketing Authorizations 38 MagMinerals 38 OTCBB LEVP 38 TSX VENTURE BM 38 plc LSE SHP 38 Exelon Patch 38 bardoxolone 38 Halfmile Mine 38 Alkaloida 38 tendering holders 38 SpectrumGold 38 Minemakers Offer 38 Information Circular 38 LLC NK Recher 38 PVR lessees 38 IVAX Corporation 38 prospectus supplement dated 38 Formal Agreements 38 Escrowed Funds 38 Nycomed GmbH 38 Million Convertible Debenture 38 APPY believes 38 merging Rozetta Cell 38 COGECO subordinate voting 38 OvaRex ® MAb 38 polymer platinate 38 NPRFC 38 IsoTis stockholders 38 Ludvik Capital Inc 38 Biologic License Application BLA 38 Somatuline R Depot 38 Repros ability 38 wholly owned subsidiaries 38 Consent Solicitations 38 wholly unconditional 38 Merger Agreement dated 38 ZAO PNG 38 xi Immtech ability 38 TSX VENTURE MDV FRANKFURT 38 definitive Arrangement Agreement 38 TSX VENTURE KTX 38 NESINA 38 distributorship agreements 38 Shonin approval 38 BayStreet.ca Research Alert 38 Pennsaid Plus 38 Acquireco 38 TimberWest Stapled Units 38 taliglucerase alfa 38 NRDC Acquisition stockholders 38 theSecurities 38 AKADO 38 MPEH TM 38 results performance orachievements 38 valopicitabine 38 OraDisc TM 38 Final Tranche 38 PNBK Holdings LLC 38 Cerro Negro concession 38 XIAPEX 38 covenant waivers 38 Petoro AS 38 Management Proxy Circular 38 Willowstar 38 subsidiaries visit http:/www.apricusbio.com 38 PBS Coals Limited 38 Amend Merger Agreement 38 InStorage Limited 38 mergers dispositions 38 accessories eyewear hosiery 38 CANALASKA URANIUM LTD 38 Currais Novos Tungsten 38 Mvelaphanda Exploration 38 Aguas Tenidas Project 38 Evoltra ® 38 received CE Conformite 38 Subscription Receipt Financing 38 transaction 38 TSX VENTURE KWG KWG 38 ONSOLIS 38 Asset Sale 38 Moydow 38 miconazole MBT 38 unknown risks anduncertainties 38 TSX VENTURE ELO 38 Cutanea Life Sciences 38 DIP financing facility 38 BCY 38 vendor unseasonable weather 38 WSE IVX 38 symbol FEL 38 MAXY alpha 38 Xcite Energy Limited 38 IS EXCLUSIVELY RESPONSIBLE FOR